Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.57 |
| ▸ | FABP3 | P05413 | 5/20 | 0.54 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.53 |
| ▸ | PPARG | P37231 | 3/20 | 0.53 |
| ▸ | PPARD | Q03181 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propane SCHEMBL28144123 | 1.00 | FAAH (0.57) | FAAHFABP3TERTPTPN1PPARG | |
| Propane SCHEMBL26102539 | 0.98 | FAAH (0.55) | FAAHFABP3TERTPTPN1PPARG | |
| SCHEMBL2905137 | 0.98 | FAAH (0.58) | FAAHFABP3TERTPTPN1PPARG | |
| Phosphoric Acid SCHEMBL28049027 | 0.93 | FABP3 (0.54) | FAAHFABP3TERTPTPN1PPARG | |
| Phosphoric Acid SCHEMBL1223979 | 0.93 | FABP3 (0.54) | FAAHFABP3TERTPTPN1PPARG | |
| Propane SCHEMBL743689 | 0.90 | KMT2A (0.48) | FABP3PTPN1PPARGPPARDPPARA | |
| Propane SCHEMBL29226175 | 0.90 | KMT2A (0.48) | FABP3PTPN1PPARGPPARDPPARA | |
| Propane SCHEMBL322960 | 0.90 | KMT2A (0.48) | FABP3PTPN1PPARGPPARDPPARA | |
| SCHEMBL1720049 | 0.88 | KMT2A (0.50) | FABP3PTPN1PPARGPPARDPPARA | |
| SCHEMBL16061965 | 0.88 | KMT2A (0.50) | FABP3PTPN1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024130374-A1 | FUNCTIONALIZED LIPOSOMAL COMPLEX, PHARMACEUTICAL COMPOSITION, COSMETIC COMPOSITION AND RELATED USES | MARJAN INDÚSTRIA E COMÉRCIO LTDA (BR) | 2024-06-27 | — | — | WO | claimed |
| CN-112716914-B | Albumin-coated cabazitaxel cation nano lipid carrier and preparation method thereof | 成都大学 | 2022-11-25 | — | — | CN | claimed |
| CN-112716914-A | Albumin-coated cabazitaxel cation nano lipid carrier and preparation method thereof | 成都大学 | 2021-04-30 | — | — | CN | claimed |
| CN-111787908-A | Method for producing lipid carrier | 以因塔师健康有限责任公司名义经营的尼克劳斯·A·费可瑞斯有限责任公司 | 2020-10-16 | — | — | CN | claimed |
| EP-1946761-B1 | CARRIER COMPOSITION FOR NUCLEIC ACID TRANSPORT | OTSUKA PHARMA CO LTD (JP) | 2013-04-03 | — | — | EP | claimed |
| US-8030075-B2 | Carrier composition for nucleic acid transport | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-10-04 | — | — | US | claimed |
| US-20090258923-A1 | Carrier Composition for Nucleic Acid Transport | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-10-15 | — | — | US | claimed |
| US-20090191261-A1 | Antibody fragment-targeted immunoliposomes for systemic gene delivery | SYNERGENE THERAPEUTICS, INC. (US) | 2009-07-30 | — | — | US | claimed |
| EP-1946761-A1 | CARRIER COMPOSITION FOR NUCLEIC ACID TRANSPORT | Otsuka Pharmaceutical Co., Ltd. (JP) | 2008-07-23 | — | — | EP | claimed |
| EP-1032369-B1 | TARGETED LIPOSOME GENE DELIVERY | UNIV GEORGETOWN (US) | 2005-05-18 | — | — | EP | claimed |
| US-6749863-B1 | COMPLEX COMPRISING A CANCER CELL TARGETING LIGAND, A CATIONIC LIPOSOME COMPRISING A CATIONIC LIPID AND A THERAPEUTIC NUCLEIC ACID | GEORGETOWN UNIVERSITY | 2004-06-15 | — | — | US | claimed |
| US-6680068-B2 | Drug delivery formulations and targeting | THE GENERAL HOSPITAL CORPORATION | 2004-01-20 | — | — | US | claimed |
| JP-2002535290-A | — | — | 2002-10-22 | — | — | JP | claimed |
| US-20020090392-A1 | Drug delivery formulations and targeting | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-07-11 | — | — | US | claimed |
| WO-2002003959-A1 | DRUG DELIVERY FORMULATIONS AND TARGETING | THE GENERAL HOSPITAL CORPORATION (US) | 2002-01-17 | — | — | WO | claimed |
| EP-1144012-A1 | LIGAND-PEG POST-COATING STABILIZED LIPOPLEX AND POLYPLEX FOR TARGETED GENE DELIVERY | GEORGETOWN UNIVERSITY (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000043043-A1 | LIGAND-PEG POST-COATING STABILIZED LIPOPLEX AND POLYPLEX FOR TARGETED GENE DELIVERY | GEORGETOWN UNIVERSITY (US) | 2000-07-27 | — | — | WO | claimed |
| WO-2024130374-A1 | FUNCTIONALIZED LIPOSOMAL COMPLEX, PHARMACEUTICAL COMPOSITION, COSMETIC COMPOSITION AND RELATED USES | MARJAN INDÚSTRIA E COMÉRCIO LTDA (BR) | 2024-06-27 | — | — | WO | disclosed |
| WO-1999059547-A1 | LONG-CIRCULATING LIPOSOMAL COMPOSITIONS | ISIS PHARMACEUTICALS, INC. (US) | 1999-11-25 | — | — | WO | disclosed |
| WO-1999025320-A1 | TARGETED LIPOSOME GENE DELIVERY | GEORGETOWN UNIVERSITY (US) | 1999-05-27 | — | — | WO | disclosed |